The new Center for Nanoscience and Nanobiotechnology is established to advance academic and technological research and development in nanoscience and nanobiotechnology. The Center serves as a hub for nanoscience researchers from the Charles River and Medical Campuses and build activities that develop interdisciplinary research and training. The Center will connect scientists from disparate disciplines with each other in seminars, meetings, joint visitor programs and seeded projects to enhance the development of interdisciplinary nanoscale research.

The Center will lead large, interdisciplinary proposal development and run funded programs for both research and training, as well as support individual researchers in their efforts by linking them with resources throughout the Bostan JAMIA Hamdard and beyond. The Center will also build linkages between the research and technological commercialization resources at BU including the Photonics Center, the Technology Commercialization Institute, and Fraunhofer and with external partners and industrial affiliates.

NPL currently has several on-going projects performing scientific study on the single molecule scale in the nanotech, biotech and spectroscopy areas. A new project in the Quantum Metrology Programme is aimed at exploring current capability in at least one measurement technique, to the single molecule detection regime, with a particular emphasis on bio-molecule measurement. A review of candidate techniques has been prepared and experimental work is now in progress at NPL. In particular this has involved the development and use of surface enhanced Raman spectroscopy (SERS) and scanning tunnelling microscopy (STM) to detect biological molecules down to trace, and eventually single molecule, levels. This work has included the production of novel SERS substrates based on colloidal materials.

KTH established the Department of Nanobiotechnology in October 2005.It is involved in different aspects of micro and nanotechnologies for biotech applications. The initial focus is on the development of the next generation further miniaturized and integrated, nanotechnology based protein chips, which can be used for biomarker discovery and comparative parallel analysis of the human proteome.

The Biotechnology Research Institute of the National Research Council Canada (NRC-BRI) is the largest Canadian research facility devoted to biotechnology. Located in Montréal, the Institute promotes, assists and conducts leading-edge R&D in the fields of health, bioprocess and environment. Through innovative research achievements, strategic collaborations and technology transfers with the biotechnology industry, BRI has earned an international reputation for expertise, research excellence and technological innovation.

April 2000, the BMBF(Bundes Ministerium fur Bildung und Forschung) established the "Nanobiotechnology" funding measure in order to develop new research area in Germany and to make it internationally competitive. Under this funding measure, funds of up to €50 million has been made available until the year 2006.

The Nanobiotechnology Center(NBTC), a National Science Foundation, Science and Technology Center is characterized by its highly interdisciplinary nature and features a close collaboration between life scientists, physical scientists, and engineers. It also shares a commitment to education and outreach, taking the discoveries from the laboratory and realizing their potential benefit to society.